These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38116329)

  • 21. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
    Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC;
    Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study.
    Winegarner A; Wakabayashi T; Hara-Ueno C; Sato T; Busch C; Fukushima Y; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Retina; 2018 Oct; 38(10):2067-2072. PubMed ID: 28902097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Navigated Laser Photocoagulation (Navilas 577+) for the Treatment of Refractory Diabetic Macular Edema.
    Kato F; Nozaki M; Kato A; Hasegawa N; Morita H; Yoshida M; Ogura Y
    J Ophthalmol; 2018; 2018():3978514. PubMed ID: 29854426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema.
    Itou J; Furushima K; Haruta M; Kato N; Arai R; Mori K; Ishikawa K; Yoshida S
    Clin Ophthalmol; 2023; 17():239-245. PubMed ID: 36698851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study.
    Busch C; Wakabayashi T; Sato T; Fukushima Y; Hara C; Shiraki N; Winegarner A; Nishida K; Sakaguchi H; Nishida K
    Sci Rep; 2019 Feb; 9(1):1561. PubMed ID: 30733512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema.
    Kusuhara S; Kishimoto-Kishi M; Matsumiya W; Miki A; Imai H; Nakamura M
    Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109622
    [No Abstract]   [Full Text] [Related]  

  • 27. Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye.
    Aoki R; Hatano M; Higashijima F; Yoshimoto T; Mikuni M; Ogata T; Kobayashi Y; Wakuta M; Kimura K
    Case Rep Ophthalmol; 2021; 12(3):841-847. PubMed ID: 34720987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.
    Mukkamala L; Bhagat N; Zarbin MA
    Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema.
    Battaglia Parodi M; Iacono P; Cascavilla ML; Zucchiatti I; Kontadakis DS; Vergallo S; Bandello F
    Eur J Ophthalmol; 2010; 20(6):1076-8. PubMed ID: 20954148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema.
    Hein M; Vukmirovic A; Constable IJ; Raja V; Athwal A; Freund KB; Balaratnasingam C
    Sci Rep; 2023 May; 13(1):8128. PubMed ID: 37208427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
    Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema.
    Murakami T; Ishihara K; Terada N; Nishikawa K; Kawai K; Tsujikawa A
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Effects of Intravitreal Aflibercept on Microvascular Regression in Eyes with Diabetic Macular Edema.
    Sugimoto M; Ichio A; Mochida D; Tenma Y; Miyata R; Matsubara H; Kondo M
    Ophthalmol Retina; 2019 Dec; 3(12):1067-1075. PubMed ID: 31446029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
    Lee J; Moon BG; Cho AR; Yoon YH
    Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal Microvascular Changes after Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema.
    Kato F; Nozaki M; Kato A; Yasukawa T
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Intravitreal Ranibizumab Resistant Radiation Retinopathy with Intravitreal Dexamethasone Implant: A Case Report.
    Sabaner MC; Dogan M
    Beyoglu Eye J; 2022; 7(4):324-328. PubMed ID: 36628082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrophy of the central neuroretina in patients treated for diabetic macular edema.
    Karst SG; Schuster M; Mitsch C; Meyer EL; Kundi M; Scholda C; Schmidt-Erfurth UM
    Acta Ophthalmol; 2019 Dec; 97(8):e1054-e1061. PubMed ID: 31228332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy.
    Gulkilik G; Taskapili M; Kocabora S; Muftuoglu G; Demirci G
    Int Ophthalmol; 2010 Dec; 30(6):697-702. PubMed ID: 20936526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant reduction of diabetic macular edema following intravitreal ranibizumab injection in the fellow eye.
    Rotsos T; Symeonidis C; Triantafillopoulou I; Kanellopoulos S; Kouris A
    Int Ophthalmol; 2014 Dec; 34(6):1271-4. PubMed ID: 25192913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.
    Karst SG; Deak GG; Gerendas BS; Waldstein SM; Lammer J; Simader C; Guerin T; Schmidt-Erfurth UM
    JAMA Ophthalmol; 2018 Apr; 136(4):315-321. PubMed ID: 29494727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.